- Home
- MOGU vs CGTX Comparison
MOGU vs CGTX Comparison
Compare MOGU & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- CGTX
- Stock Information
- Founded
- MOGU 2011
- CGTX 2007
- Country
- MOGU China
- CGTX United States
- Employees
- MOGU N/A
- CGTX N/A
- Industry
- MOGU Business Services
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- CGTX Health Care
- Exchange
- MOGU Nasdaq
- CGTX Nasdaq
- Market Cap
- MOGU 18.7M
- CGTX 16.1M
- IPO Year
- MOGU 2018
- CGTX 2021
- Fundamental
- Price
- MOGU $2.33
- CGTX $0.61
- Analyst Decision
- MOGU
- CGTX Strong Buy
- Analyst Count
- MOGU 0
- CGTX 6
- Target Price
- MOGU N/A
- CGTX $8.30
- AVG Volume (30 Days)
- MOGU 4.5K
- CGTX 20.0M
- Earning Date
- MOGU 01-03-2025
- CGTX 11-13-2024
- Dividend Yield
- MOGU N/A
- CGTX N/A
- EPS Growth
- MOGU N/A
- CGTX N/A
- EPS
- MOGU N/A
- CGTX N/A
- Revenue
- MOGU $19,801,126.00
- CGTX N/A
- Revenue This Year
- MOGU N/A
- CGTX N/A
- Revenue Next Year
- MOGU N/A
- CGTX N/A
- P/E Ratio
- MOGU N/A
- CGTX N/A
- Revenue Growth
- MOGU N/A
- CGTX N/A
- 52 Week Low
- MOGU $1.62
- CGTX $0.34
- 52 Week High
- MOGU $3.58
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- MOGU 59.92
- CGTX 62.98
- Support Level
- MOGU $2.17
- CGTX $0.43
- Resistance Level
- MOGU $2.49
- CGTX $1.29
- Average True Range (ATR)
- MOGU 0.14
- CGTX 0.10
- MACD
- MOGU 0.03
- CGTX 0.02
- Stochastic Oscillator
- MOGU 91.07
- CGTX 23.85
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.